RDY Days Sales Outstanding from 2010 to 2025

RDY Stock  USD 13.94  0.03  0.21%   
Dr Reddys Days Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Sales Outstanding will likely drop to 79.91 in 2025. During the period from 2010 to 2025, Dr Reddys Days Sales Outstanding regression line of annual values had r-squared of  0.03 and arithmetic mean of  113.86. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
94.49
Current Value
79.91
Quarterly Volatility
17.70077582
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 2.1 B, Total Revenue of 337.1 B or Gross Profit of 197.6 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0271 or PTB Ratio of 0.86. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Dr Reddys Laboratories over the last few years. It is Dr Reddys' Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Pretty Stable
   Days Sales Outstanding   
       Timeline  

RDY Days Sales Outstanding Regression Statistics

Arithmetic Mean113.86
Geometric Mean112.45
Coefficient Of Variation15.55
Mean Deviation13.56
Median118.60
Standard Deviation17.70
Sample Variance313.32
Range60.8366
R-Value(0.18)
Mean Square Error325.32
R-Squared0.03
Significance0.51
Slope(0.65)
Total Sum of Squares4,700

RDY Days Sales Outstanding History

2025 79.91
2024 94.49
2023 104.99
2022 107.6
2021 136.66
2020 118.67
2019 129.1

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding 94.49  79.91 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.